Home > News > Industry > Pharma News > Biocon Academy, Keck...

Biocon Academy, Keck Graduate Institute to launch 18th batch of Biocon KGI Certificate Program in Biosciences

By - Ruchika Sharma
Published On 2021-01-15 07:15 GMT   |   Update On 2021-01-15 07:15 GMT

Bengaluru: Biocon Academy, a brainchild of Biocon Chairperson Kiran Mazumdar-Shaw, founded in 2013 as a CSR initiative and a Centre of Excellence for Advanced Learning in Applied Biosciences, is all set to launch 18th batch of its flagship program in partnership with Keck Graduate Institute, California, in its effort to bridge the gap between the academia and industry.The launch was after...

Login or Register to read the full article
Register Now

Bengaluru: Biocon Academy, a brainchild of Biocon Chairperson Kiran Mazumdar-Shaw, founded in 2013 as a CSR initiative and a Centre of Excellence for Advanced Learning in Applied Biosciences, is all set to launch 18th batch of its flagship program in partnership with Keck Graduate Institute, California, in its effort to bridge the gap between the academia and industry.

The launch was after the massive success of its 17 batches of Biocon KGI Certificate Program in Biosciences and having accomplished 100 per cent placement record in all our batches even during the pandemic.
Program Dean Bindu Ajit said, "Biocon Academy is all excited to launch the 18th batch of its flagship program 'Biocon KGI Certificate Program in Biosciences'".
"It has been a wonderful journey and our education partner Keck Graduate Institute, California, has been a great team to work with. We have also accomplished a 100 per cent placement record in all our batches and other programs, even during the pandemic, which itself is a testament that speaks about the success and impact of Biocon Academy, she added.
She said " While we are looking forward to having the class onsite as soon as possible, we will do our best to ensure the students won't miss out on anything if in case we are going to continue with virtual training based on the current situation. Wishing students all the best for this new journey."

Read also: Biocon subsidiary approves primary equity investment of Rs 555 crore by Abu Dhabi-based ADQ



Tags:    
Article Source : UNI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Aurobindo Pharma receives tax demand of over Rs 13 crore, including interest, penalty
Aurobindo Pharma arm gets 7 USFDA observations for Alwar facility
Delhi HC slaps Rs 3 lakh fine on drugmaker for violating Pfizer trademark of Viagra
Dr Reddy's Labs unveils Doxycycline Capsules, 40 mg in US to treat inflammatory lesions of rosacea
Licences of 14 products suspended: Patanjali Ayurved calls for legal action against Uttarakhand SLA
NPPA Revises Ceiling Prices Of Coronary Stents
Form expert panel to examine possible side effects, risk factors of Covishield vaccine; seeks plea filed in SC
India, New Zealand eye to increase collaboration in pharma sector